Sansan Lin, PhD – Principal

Dr. Lin has over 15 years of diversified experience in technology evaluation and implementation for diagnostics, assay development and HTS, LabChip microfluidic technology, GPCR biochemistry/molecular pharmacology, protein biochemistry/ crystallization, and lipid membrane biochemistry. In recent years, her work has focused on strategic development and technology assessment in the field of molecular diagnostics for a major pharma/biotech company. Dr. Lin has authored numerous technology and company reports, published 13 scientific papers in peer-reviewed journals, and presented her research work at various meetings. She obtained her BS in Pharmaceutical Sciences and her MS in Pharmaceutical Analysis and Clinical Pharmacology from Shanghai Medical University in China and her PhD in Biophysical Chemistry at Stanford University in California where she was a Howard Hughes Medical Institute Postdoctoral Fellow. Dr. Lin is fluent in Chinese.

< Back to Team